GINCELERATOR 3.0 Accelerator Program
GINSERV's DST-NIDHI supported 6-month accelerator for healthtech/medtech startups at TRL 5-8, offering up to ₹10L grant, mentorship, and hospital access.
- Funding amount
- ₹10L (grant)
- Funding type
- Grant
- Provider
- GINSERV (Academic)
- Application deadline
- Closed (16 Jan 2026)
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
Overview
GINCELERATOR 3.0 is a flagship accelerator program supported by the DST–NIDHI initiative and run by GINSERV. It is specifically designed for healthtech and medtech startups aiming to move beyond validation and achieve large-scale hospital adoption and commercialization. The program provides a structured 6-month journey focused on clinical adoption, real-world healthcare deployment, and market scalability.
Selected startups gain direct access to hospitals and clinical experts, mentorship from industry and medical leaders, investor readiness support, and exposure to funding opportunities. Participants also receive infrastructure support, curated workshops, and masterclasses covering regulatory readiness, business models, and go-to-market strategies. Additionally, prize money is offered to accelerate growth and impact in the healthcare ecosystem.
Highlights
- Up to ₹10L grant funding for healthtech/medtech startups.
- 6-month accelerator program supported by DST–NIDHI.
- Focus on clinical adoption, hospital deployment, and market scalability.
- Open to DPIIT-registered startups at TRL 5-8, post-MVP or early revenue stage.
- Direct access to hospitals, clinical experts, and industry mentors.
- Workshops and masterclasses on regulatory readiness and go-to-market strategies.
Who can apply
The program is open to DPIIT-registered startups operating in healthtech or medtech domains. Applicants must have validated, regulatory-ready solutions at Technology Readiness Levels (TRL) 5 to 8 and be at the post-MVP or early revenue stage. Eligible focus areas include AI and IoMT-based diagnostics, remote monitoring and early warning systems, oncology, neurology, cardiology, infectious diseases, radiology, hospital automation, AI-based clinical decision support, and digital health platforms. Startups should be ready to scale from pilots to wider clinical and hospital adoption.
GINCELERATOR 3.0 Accelerator Program is open to startups at any stage. It is open to startups registered anywhere in India.
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
Deadline & timing
The most recent application window for GINCELERATOR 3.0 Accelerator Program closed on 16 Jan 2026. Many programmes run repeat cohorts, so it is worth checking the official site for the next round.
What the funding covers
Startups selected for GINCELERATOR 3.0 receive up to ₹10L in grant funding. In addition, they benefit from a structured accelerator journey that includes direct access to hospitals and clinical experts, mentorship from industry and medical leaders, investor readiness support, exposure to funding opportunities, infrastructure support, curated workshops and masterclasses, and prize money to support growth.
About the provider
GINCELERATOR 3.0 Accelerator Program is offered by GINSERV, an academic institution. It is delivered directly by GINSERV as a grant. You can verify current details and timelines on the provider's official website before applying.
Documents you’ll need
Before you apply to GINCELERATOR 3.0 Accelerator Program, keep the following documents ready:
- A pitch deck or short business plan describing the problem, product and traction
- Company registration documents and PAN
- Founder identification (PAN / Aadhaar) and brief profiles
- Recent financial statements or projections
- Product details — a demo, prototype or working link if available
Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.
Who this is best for
GINCELERATOR 3.0 Accelerator Program is best suited for startups in India seeking non-dilutive funding of ₹10L. If that describes your startup, review the eligibility criteria above before applying.
Frequently asked questions
What is the total funding amount offered?
The program offers up to ₹10L in grant funding, along with prize money and other non-financial benefits.
What is the application deadline?
The deadline for applications is January 16, 2026.
Who is eligible to apply?
DPIIT-registered startups working in healthtech or medtech domains with solutions at TRL levels 5 to 8, and at post-MVP or early revenue stage are eligible.
Which sectors are covered?
Eligible focus areas include AI and IoMT-based diagnostics, remote monitoring, oncology, neurology, cardiology, infectious diseases, radiology, hospital automation, AI-based clinical decision support, and digital health platforms.
Does the program take equity?
The program provides grant funding, which is non-dilutive and does not require equity.
Is DPIIT registration required?
Yes, startups must be DPIIT-registered to apply.
What are the key benefits besides funding?
Selected startups get access to hospitals and clinical experts, mentorship from industry and medical leaders, investor readiness support, infrastructure support, workshops, and prize money.
How long is the accelerator program?
It is a structured 6-month accelerator journey.
How do I apply?
Applications are accepted online via the GINSERV community portal at the provided apply URL.
What documents are typically needed?
The provided facts do not list specific documents, but DPIIT registration and details on TRL level, solution validation, and revenue stage are likely required.
Who offers GINCELERATOR 3.0 Accelerator Program?
GINCELERATOR 3.0 Accelerator Program is offered by GINSERV, an academic institution. It is provided as non-dilutive funding.
More funding from GINSERV
GINSERV runs another program listed on startupfunds — compare them before you decide where to apply.
Alternatives to GINCELERATOR 3.0 Accelerator Program
Not sure GINCELERATOR 3.0 Accelerator Program is the right fit, or already applied? These are other grants open to Indian startups that founders shortlist alongside it.
Questions from founders
Ask anything about eligibility, documents or the process — answered by the community.
No questions yet — be the first to ask.